Wegovy injections have been approved for long-term use by the FDA, provided that they are prescribed and monitored by a healthcare provider. Clinical trials have shown that Wegovy is effective and generally safe for extended use, particularly in individuals who continue to benefit from the treatment and do not experience significant adverse effects. Long-term safety studies indicate that the most common side effects, such as gastrointestinal issues, tend to diminish over time as the body adjusts to the medication.

However, long-term use of Wegovy should be carefully monitored, especially in individuals with a history of thyroid cancer, pancreatitis, or other specific medical conditions. Regular follow-ups with a healthcare provider are essential to ensure that the medication remains effective and safe over time. Any potential risks should be weighed against the benefits of sustained weight loss, especially in individuals with obesity-related health conditions.

Wegovy injections are primarily used as a medical intervention for chronic weight management in adults who are overweight or obese. Specifically, they are indicated for individuals with a body mass index (BMI) of 30 or greater, or for those with a BMI of 27 or greater who also have weight-related conditions such as type 2 diabetes, hypertension, or high cholesterol. Wegovy works by mimicking a hormone called GLP-1 (glucagon-like peptide-1) that targets areas of the brain involved in regulating appetite and food intake, helping individuals feel fuller longer and reducing their overall caloric intake.

In addition to weight loss, Wegovy injections may also provide ancillary health benefits, such as improved blood pressure, better control of blood glucose levels, and lower cholesterol levels, especially when combined with a healthy diet and exercise. The goal of Wegovy treatment is not just to achieve weight loss but also to sustain it over time, reducing the risk of developing obesity-related health conditions and improving overall quality of life.